Brief: Annexin Pharmaceuticals To Get SEK 50 Mln From Rights Issue
March 26 (Reuters) - Annexin Pharmaceuticals AB (publ) ANNX.ST: TO RECEIVE APPROXIMATELY SEK 50 MILLION FROM RIGHTS ISSUE RIGHTS ISSUE 100 PERCENT SUBSCRIBED Source text: ID:nMFN2fpc7y Further company coverage: ANNX.ST (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed